IMF Videos Search Content For Care Partner (95) Patient (94) Healthcare Professional (19) Healthcare Provider (19) Series - Any - ASCO/EHA (4) ASH (4) Ask Dr. Durie (37) Community Workshops (2) Emerging Therapies (4) Facebook Live (9) Health Equity (1) Inspirational (1) Living Well with Myeloma (14) Myeloma in a Minute (5) Myeloma Made Simple (4) Myeloma University (8) Patient & Family Webinar (2) Q&A (15) Treatments (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (48) High-Risk Myeloma (33) High-risk Smoldering Myeloma (18) Late Relapse (4–6 Lines of Therapy) (50) MGUS (26) Newly Diagnosed (Pre-Treatment or First Treatment) (43) Smoldering Myeloma (33) Types of Therapy Immunomodulatory drugs (IMiDs) (28) Immunotherapies (CAR T; BiTE, etc.) (44) Monoclonal antibodies (18) Proteasome inhibitors (13) Stem cell transplant (17) Steroids (20) Supportive Care (97) Year Published 2026 (9) 2025 (24) 2024 (11) 2023 (19) 2022 (9) 2021 (5) 2020 (2) 2019 (4) 2018 (6) 2017 (9) 2016 (5) 2015 (10) Trusted Voices Dr. Brian GM Durie (34) Dr. Joseph Mikhael (31) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (18) Donna Catamero, ANP-BC, OCN, CCRC (3) Dr. Saad Usmani (1) Dr. Tom Martin (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Is good sleep quality important for myeloma patients? August 24, 2023 Ask Dr. Durie What are the side effects and difficulties with new myeloma immune therapies? August 17, 2023 Ask Dr. Durie Myeloma University | Selinexor and Venetoclax; Two Drugs Used to Treat Myeloma in a Relapse Setting July 18, 2023 Myeloma University Myeloma University | Learn about Steroids, IMiDs, and PIs: Three Classes of Drugs to Treat Myeloma July 18, 2023 Myeloma University Myeloma University | Learn the Basics of Treatment Selection in Upfront and Relapse Settings July 18, 2023 Myeloma University Myeloma University | The Patient Journey and CAR-T Therapy Management in Multiple Myeloma July 18, 2023 Myeloma University Myeloma University | Learn About Renal (Kidney) Impairment in Patients with Multiple Myeloma July 18, 2023 Myeloma University Comparing Health Related Quality of Life in TCE RRMM: Ide-cel vs. Standard Regimens June 26, 2023 ASCO/EHA Disparities in multiple myeloma: A global perspective on drug toxicity trends June 13, 2023 ASCO/EHA Elranatamab: Extended Follow-up & Biweekly Admin for RRMM | MagnetisMM-3 Study June 13, 2023 ASCO/EHA Myeloma ACTION Month: Special Q&A with Beth Faiman March 31, 2023 Facebook Live Tocilizumab pre-treatment reduced cytokine release syndrome in relapsed/refractory multiple myeloma patients receiving cevostamab February 3, 2023 ASH Load More
